- Report
- November 2023
- 100 Pages
Global
From €5708EUR$5,950USD£4,903GBP
- Report
- November 2023
- 172 Pages
Global
From €5708EUR$5,950USD£4,903GBP
- Report
- April 2024
- 175 Pages
Global
From €4796EUR$5,000USD£4,120GBP
- Report
- February 2024
- 250 Pages
Global
From €4796EUR$5,000USD£4,120GBP
- Report
- February 2024
- 175 Pages
Global
From €4796EUR$5,000USD£4,120GBP
- Report
- February 2024
- 175 Pages
Global
From €4796EUR$5,000USD£4,120GBP
- Report
- February 2024
- 175 Pages
Global
From €4796EUR$5,000USD£4,120GBP
- Report
- February 2024
- 200 Pages
Global
From €4796EUR$5,000USD£4,120GBP
- Report
- January 2024
- 175 Pages
Global
From €4796EUR$5,000USD£4,120GBP
- Report
- January 2024
- 200 Pages
Global
From €4796EUR$5,000USD£4,120GBP
- Report
- January 2024
- 200 Pages
Global
From €4796EUR$5,000USD£4,120GBP
- Report
- January 2024
- 200 Pages
Global
From €4796EUR$5,000USD£4,120GBP
- Report
- December 2023
- 200 Pages
Global
From €4796EUR$5,000USD£4,120GBP
- Report
- December 2023
- 200 Pages
Global
From €4796EUR$5,000USD£4,120GBP
- Report
- December 2023
- 200 Pages
Global
From €4796EUR$5,000USD£4,120GBP
- Report
- November 2023
- 150 Pages
Global
From €4653EUR$4,850USD£3,997GBP
- Report
- September 2023
- 234 Pages
Global
From €4653EUR$4,850USD£3,997GBP
- Report
- June 2023
- 235 Pages
Global
From €4653EUR$4,850USD£3,997GBP
- Report
- June 2023
- 200 Pages
Global
From €4653EUR$4,850USD£3,997GBP
- Report
- December 2023
- 164 Pages
Global
From €2254EUR$2,350USD£1,937GBP
Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more